Related Experiment Video

Updated: Dec 31, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.7K

Selective interstitial doxorubicin for recurrent glioblastoma

Valerii Matcovschii1, Dan Lisii1, Valentin Gudumac2

  • 1Neurosurgery Department Institute of Neurology Institute of Neurology and Neurosurgery Chisinau Moldova.

Clinical Case Reports
|January 2, 2020
PubMed
Summary

Interstitial chemotherapy offers a promising approach for brain tumors, bypassing the blood-brain barrier. This method may allow effective doxorubicin delivery to tumor cells while minimizing neurotoxicity.

Keywords:
doxorubicinglioblastomainterstitial chemotherapyrecurrencestem cell culture

More Related Videos

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

19.0K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.9K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K